https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-31 / Oncoimmunology 2015 Aug;4(8):e970462
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-31 / Oncoimmunology 2015 Aug;4(8):e9704622014-10-31 00:00:002019-02-15 08:45:09Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e0024
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-29 / Rambam Maimonides Med J 2014 Oct;5(4):e00242014-10-29 00:00:002019-02-15 08:39:37Dendritic cell cancer vaccines: from the bench to the bedside
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-21 / J. Cell. Mol. Med. 2015 Feb;19(2):340-502014-10-21 00:00:002014-10-21 00:00:00Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-18 / Expert Opin Biol Ther 2015 Jan;15(1):79-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-18 / Expert Opin Biol Ther 2015 Jan;15(1):79-942014-10-18 00:00:002019-02-15 08:47:21Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-15 / Mol Med Rep 2015 Jan;11(1):327-322014-10-15 00:00:002019-02-15 09:18:18Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-15 / Mol Med Rep 2015 Jan;11(1):317-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-15 / Mol Med Rep 2015 Jan;11(1):317-262014-10-15 00:00:002014-10-15 00:00:00Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-07 / Semin. Oncol. 2014 Dec;41(6):714-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-07 / Semin. Oncol. 2014 Dec;41(6):714-292014-10-07 00:00:002019-02-15 09:17:06Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-72014-10-06 00:00:002021-11-15 16:54:44Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-2406
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-24062014-10-06 00:00:002021-11-16 07:53:33Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-01 / Gan To Kagaku Ryoho 2014 Oct;41(10):1261-3
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-01 / Gan To Kagaku Ryoho 2014 Oct;41(10):1261-32014-10-01 00:00:002019-02-15 09:17:08[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer – analyses by cancer type and recurrence form]
